Published 07:21 IST, September 22nd 2020
COVID-19 vaccine: AstraZeneca releases trial blueprint, aims for 50% effectiveness
Amid the COVID-19 pandemic, AstraZeneca has released a blueprint for its COVID-19 vaccine Phase-3 trials where it is aiming for 50% effectiveness
null | Image:
self
Advertisement
07:21 IST, September 22nd 2020